This report covers recent developments in the health sector, including proposed US federal budget cuts affecting scientific ...

A wave of new drugs have revolutionised the weight loss industry. Now, getting your hands on one popular medication could get ...

The Trump administration proposes significant budget cuts affecting health and research sectors. Texas reports 683 measles cases amid nationwide outbreaks. Medical device demand boosts Stryker's ...

When the stock market experiences a sharp decline, as it did after the Trump administration announced tariffs on its trade partners and China responded with retaliatory tariffs, many investors start ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

PRESS RELEASE FROM THE MINISTRY OF HEALTH AND HUMAN SERVICES Cockburn Town, Turks and Caicos Islands, 2nd May 2025: In ...

Novo Nordisk ( ($NVO) ) has risen by 10.56%. Read on to learn why. Novo Nordisk has seen a notable increase in its stock price, rising by 10.56% ...

We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take a ...

Novo Nordisk shares rose by more than 5% after the Danish weight-loss drug maker said the Food and Drug Administration accepted a new drug application for a pill form of its popular Wegovy injection.

Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on the ...

A decision is expected in the fourth quarter of 2025.